„II. Grad“
Suchergebnisse
662 Treffer
-
Molecular–genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient’s prognosis
-
Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis
-
Basiswissen Bilanzanalyse – schneller Einstieg in Jahresabschluss, Bilanz und GuV
-
Nuclear Power: History, Materials, Economics and Future
-
Analysis of patterns of failure and appraisal of postoperative radiation field for grade II–III meningioma
-
Bone Defect Management with Vascularized Fibular Grafts in the Treatment of Grade III-IV Osteomyelitis
-
Cetuximab – Grade III infusion-related toxicity: case report
-
Conjugate gradient methods using value of objective function for unconstrained optimization
-
A Combination of Self‑Expansile Metallic Stent and External Beam Radiotherapy in Management of Advanced Esophageal Carcinoma with Grade III Dysphagia and Beyond
-
Lokale Behandlung von Grad-IIa-Verbrennungen – Wirksamkeit und Verträglichkeit eines neuartigen hydrosomalen Wundgels im Vergleich zu Silbersulfadiazin-Creme
-
Analysis of Gene Expression in Hondroblasts of Vertebral Body Growth Plates in Patients with Grade III–IV Idiopathic Scoliosis
-
Die Heilungsergebnisse der frischen Dammrisse III. Grades
-
Clinical and radiographical results after double flip button stabilization of acute grade III and IV acromioclavicular joint separations
-
DG-RAR for the treatment of symptomatic grade III and grade IV haemorrhoids: a 12-month multi-centre, prospective observational study
-
Reply to invited comment on “Partial stapled hemorrhoidopexy versus circular stapled hemorrhoidopexy for grade III–IV prolapsing hemorrhoids: a two-year prospective controlled study” by I. Khubchandani
-
Total auricular reconstruction with autogenous costal cartilage framework for congenital microtia (grade-III)
-
Nukleärer DNA-Gehalt und Zellzyklusanalyse beim Ovarialkarzinom FIGO III/IV: Entscheidungshilfe für eine individualisierte Therapie?
-
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III–IV acute graft-versus-host disease
-
Vergleich und Ergebnis von Schultereckgelenkverletzungen II. und III. Grades
-
Felstouren im II. und III. Grad – 46 Routen zwischen Salzburg und Oberstdorf